SAN FRANCISCO DDC STUDY: KS DIAGNOSIS IS ALLOWED

Our last issue (AIDS TREATMENT NEWS #82) included an announcement that a trial of the antiviral DDC is seeking volunteers in San Francisco. We had been told that persons with KS would not be accepted. But the protocol was still being developed at that time, and the final version does allow persons with KS in the study, if they are not using chemotherapy or radi- ation when they enter it.

Volunteers must have a T-helper count lower than 200, and either have had pneumocystis within four months before starting the trial, or have certain other AIDS-related symptoms. They must not have used AZT, and not have used acyclovir for extended periods.

For more information, call Elena Swann, 415/565-6272.